Take a pass on Absolute Software: Paradigm Capital

Absolute Software’s (TSX:ABT) fiscal fourth quarter posted revenue in-line with expectations along with a consensus beat on EBITDA, an overall positive result, says analyst Kevin Krishnaratne of Paradigm Capital, who nonetheless maintains his “Hold” recommendation and 12-month target price of C$8.00.

Security and tracking software company Absolute reported Q4/18 revenue of $24.1 million, a four per cent year-over-year increase, and an adjusted EBITDA of $3.1 million, representing 13 per cent of revenue. (All figures in US dollars unless noted otherwise.)

Interim CEO Steve Munford said that the quarter showed continued momentum in its Enterprise sales, particularly in the healthcare, financial services and professional services verticals.

“Moving into our new fiscal year, we expect to increase our emphasis on these verticals while leveraging our strong OEM channel relationships to drive new customer acquisition opportunities,” Munford said in a press release on Monday. “Incremental investments in these focus areas will be funded within our existing cost structure, meaning continued operating margin expansion as our top line continues to grow.”

Krishnaratne points to Q4 highlights including recurring revenue up five per cent year-over-year to $22.9 million and the $3.1 million EBITDA, which beat his estimate of $2.5 million as well as the Street’s $2.3 million. The analyst also notes that management guidance for fiscal 2019 arrived slightly under expectations for revenue ($96.0 – $99.0 million, compared to consensus and Krishnaratne’s $100 million) but above expectations for EBITDA margin (13-16 per cent from ABT versus the Street’s 13-16 per cent).

“While we were pleased with Q4 results and the outlook for margin, which was better than forecast, we look forward to consolidated revenue growth trends moving closer to double-digit gains before suggesting investors become more constructive on the stock,” says Krishnaratne.

“Our target reflects an EV/Sales multiple on FY19/FY20 estimates of ~2.0x (unchanged from our prior valuation based on a 2.0x EV/Sales multiple on FY19), which is a discount to other Information Security comparables (4.5x) and Canadian Software peers (6.2x),” says the analyst. “Higher multiples for the peers we track are a result of higher revenue/EBITDA growth, margins, or M&A-driven business. As such, we continue to believe Absolute should be valued at a discount to other information security and Canadian software peers.”

Krishnaratne’s $8.00 target represents a potential return including dividend of 7.6 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: abt
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

15 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

22 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

23 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

23 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago